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Neurons depend on oxidative phosphorylation for energy generation,
whereas astrocytes do not, a distinctive feature that is essential for
neurotransmission and neuronal survival. However, any link between
these metabolic differences and the structural organization of the
mitochondrial respiratory chain is unknown. Here, we investigated
this issue and found that, in neurons, mitochondrial complex I is
predominantly assembled into supercomplexes, whereas in astro-
cytes the abundance of free complex I is higher. The presence of free
complex I in astrocytes correlates with the severalfold higher reactive
oxygen species (ROS) production by astrocytes compared with
neurons. Using a complexomics approach, we found that the complex
I subunit NDUFS1 was more abundant in neurons than in astrocytes.
Interestingly, NDUFS1 knockdown in neurons decreased the associa-
tion of complex I into supercomplexes, leading to impaired oxygen
consumption and increased mitochondrial ROS. Conversely, over-
expression of NDUFS1 in astrocytes promoted complex I incorporation
into supercomplexes, decreasing ROS. Thus, complex I assembly into
supercomplexes regulates ROS production and may contribute to the
bioenergetic differences between neurons and astrocytes.
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The brain is a metabolically demanding organ (1) that requirestight cooperation between neurons and astrocytes (2). Astro-
cytes provide crucial metabolic and structural support (3, 4) and are
key players in neurotransmission (5–7) and behavior (8). The status
of many major redox couples in the brain is also regulated by as-
trocytes (9), through their high content of antioxidant compounds
and enzymes (10) and by the constitutive stabilization of the mas-
ter antioxidant transcriptional activator, nuclear factor erythroid
2-related factor 2 (Nrf2) (11). Thus, astrocytes are equipped to protect
themselves when exposed to excess reactive oxygen species (ROS)
(12) and reactive nitrogen species (13, 14). Moreover, astrocytes also
provide nearby neurons with protective antioxidant precursors
through a cell-signaling mechanism involving glutamate receptor ac-
tivation by neurotransmission (11, 15, 16). The tight coupling between
astrocytes and neurons therefore helps in energy and redox metabo-
lism during normal brain function.
Intriguingly, the ATP used by neurons is supplied by oxidative
phosphorylation, whereas most energy needs of astrocytes are met by
glycolysis (17). In fact, the survival of neurons requires oxidative
phosphorylation (18, 19). The different energy metabolisms of the
two cell types are closely coupled, with astrocytes releasing the gly-
colytic end product, lactate, which is used by neighboring neurons to
drive oxidative phosphorylation (20–22). As the molecular mecha-
nisms underlying the markedly different modes of ATP production in
the two cell types are not understood, we investigated whether the
organization of the mitochondrial respiratory chain in brain cells
could contribute. Here, we report that the extent of supercomplex
formation by the mitochondrial respiratory chain is quite different in
neurons and astrocytes and that these structural differences regulate
different rates of mitochondrial ROS production and respiration.
Results
More Complex I Is Free in Astrocytes than in Neurons, Affecting
Mitochondrial Function and ROS Production. Mitochondrial com-
plexes can organize into supercomplexes in a process that has been
claimed to regulate electron transfer efficiency (23). Therefore, we
assessed whether the structural organization of the mitochondrial
respiratory chain differed between neurons and astrocytes. To do
this, digitonin-solubilized mitochondria (24) from primary cultures
of C57BL/6 mouse neurons and astrocytes were analyzed by blue
native gel electrophoresis (BNGE). Complex I occurred both on its
own and also bound with complex III, notably in a I+III2 super-
complex and, to a lesser extent, in a I2+III2 supercomplex (Fig. 1A)
(25). The composition of these supercomplexes was confirmed by
electrotransfer of the proteins to nitrocellulose followed by immu-
noblotting against either a complex I subunit (NADH:ubiquinone
oxidoreductase subunit B8, NDUFB8) or a complex III subunit
(ubiquinol-cytochrome C reductase core protein III, UQCRC2)
(Fig. 1A). Interestingly, we observed a significant difference between
astrocytes and neurons in the proportion of complex I that was free
relative to that which was part of a supercomplex. The ratio of free
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to assembled complex I was higher, whereas the ratio of free to as-
sembled complex III was lower, in astrocytes compared with neurons
(Fig. 1A and Fig. S1A). This pattern of respiratory chain organization
was confirmed in freshly isolated neurons and astrocytes (Fig. S1 B
and C) and in cells cultured at 11% O2, instead of 21% (Fig. S1D).
The relative abundance of complex I versus complex III in astrocytes
was twice that in neurons, as judged byWestern blotting of whole-cell
extracts (Fig. 1B). These data suggest that the relatively low amount
of complex III in astrocytes may limit I–III supercomplex formation,
and thereby increase the proportion of complex I in astrocytes that is
not present in supercomplexes.
To further interrogate the differences in respiratory chain as-
sembly between these two cell types, we next performed proteomic
quantitative analyses of complex I subunits by mass spectrometry
of gel slices from blue native gels of digitonin-solubilized mito-
chondria from astrocytes or neurons. As shown in Fig. 1C, mea-
surement of complex I subunits showed that their amounts present
in free complex I, relative to those present in I+III2 plus I2+III2
supercomplexes, was about twofold greater in astrocytes com-
pared with neurons. This was further assessed by assaying rote-
none-sensitive NADH-ubiquinone oxidoreductase activity in
proteins electroeluted from blue native gel slices containing the
supercomplexes (SC) or free complex I (CI). This showed that the
NADH-ubiquinone oxidoreductase activity in the free complex
I band was higher in astrocytes than in neurons (Fig. 1D). Because
complex I catalyzes O2
•− production (26), we next determined
ROS in complex I-containing slices excised from the blue native
gels, and we found that ROS production from the free complex
I band was higher in astrocytes than in neurons (Fig. 1E). These
results confirm that the ratio of free complex I to that present in
supercomplexes is higher in astrocytes than it is in neurons.
Because the organization of respiratory complexes into super-
complexes is reported to affect mitochondrial function and ROS
production (24, 25), we next determined O2 consumption in mi-
tochondria isolated from astrocytes and neurons. State 3 pyruvate/
malate-driven (Fig. 1F) and succinate-driven (Fig. S1E) O2 con-
sumption in astrocytes was significantly lower than that in neurons.
To ascertain whether there were any differences in mitochondrial
ROS production between these two cell types, we also determined
the rate of H2O2 formation in isolated mitochondria. As shown in
Fig. 1G, mitochondrial ROS production was higher in mitochon-
dria from astrocytes than from neurons, either from endogenous
substrates or in the presence of pyruvate/malate. Thus, the pres-
ence or absence of complex I in supercomplexes in the respiratory
chain in neurons and astrocytes correlates with differences in
mitochondrial function and ROS production.
Astrocytes Produce More Mitochondrial ROS than Neurons. To see
whether the differences in ROS production by mitochondria isolated
from neurons and astrocytes also occurred in intact cells, we de-
termined the rate of H2O2 generation by intact neurons and astro-
cytes in primary cultures from mice and rats. Astrocytes produced
H2O2 about one order of magnitude faster than neurons, from
both rat and mouse and under all culture conditions investigated
(Fig. 2A and Fig. S2 A–C). We next assessed mitochondrial ROS
production (27) using the mitochondria-targeted probes MitoSox
and MitoB (28) in intact cells. The MitoSox fluorescence and the
MitoP/MitoB ratio were higher in astrocytes than in neurons
(Fig. 2 B and C and Fig. S2 D–H), indicating an elevation of mi-
tochondrial ROS in astrocytes compared with neurons under these
conditions. Interestingly, the differences in MitoSox fluorescence
and in mitochondrial H2O2 production, between neurons and
astrocytes, were unchanged after Δψm disruption with carbonyl
cyanide m-chlorophenyl hydrazone (CCCP) (Fig. 2 D and E),
suggesting that the difference is not due to differences in Δψm
affecting probe distribution. Other nonmitochondrial ROS sources,
such as xanthine oxidase, NADPH oxidases, and nitric oxide syn-
thase, did not appear to contribute to the high rate of ROS
Fig. 1. Different assembly of complex I into supercomplexes between neurons
and astrocytes correlates with ROS production and mitochondrial respiration.
(A) Digitonin-solubilized isolated mitochondria from mouse astrocytes and
neurons were subjected to blue native gel electrophoresis (BNGE) followed by
in-gel complex I activity assay. Complex I occurs both free and bound with
complex III (I+III2 and I2+III2 supercomplexes). Direct electrotransfer of the na-
tive proteins to nitrocellulose followed by immunoblotting against NDUFB8
(a complex I subunit) or UQCRC2 (a complex III subunit). (B) Western blotting
against NDUFB8 and UQCRC2 in whole-cell protein extracts showing the rela-
tive abundance of complex I versus complex III in astrocytes and neurons.
(C) Slices were excised from digitonin-solubilized isolated astrocyte and neu-
ronal mitochondria blue native gels, and the abundances of complex I subunits
in free complex I (CI), relative to the abundance of those in I+III2 and I2+III2
supercomplexes (SC), were assessed by complexomics. (D) Rotenone-sensitive
NADH-ubiquinone oxidoreductase activity of the excised and electroeluted
free complex I and complex I-supercomplexes bands from the blue native gel in
astrocytes and neurons. Data were not normalized per protein abundance in
the eluate, as we aimed to assess the amount of total complex I activity present
in each band. (E) In-gel H2O2 production in the excised SC and CI bands from
the BNGE in astrocytes and neurons. H2O2 production values were normalized
by the NADH dehydrogenase-activity band intensity obtained in the BNGE.
(F) Pyruvate/malate (5 mM each)-driven mitochondrial oxygen consumption in
isolated mitochondria from neurons or astrocytes under state 2 (0 mM ADP) or
state 3 (1 mM ADP), either in the absence or in the presence of KCN (2 mM).
(G) Rate of H2O2 production assessed using the AmplexRed assay, in mito-
chondria isolated from neurons and astrocytes, in the presence and absence of
pyruvate/malate (5 mM each). Data are the mean values ± SEM from n = 3–4
independent culture preparations (Student’s t test; ANOVA post hoc Bonfer-
roni). *P < 0.05.
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production in astrocytes (Fig. S3 and Table S1). Thus, we conclude
that mitochondrial ROS production is greater in astrocytes than
in neurons.
We next investigated mitochondrial ROS production in neurons
and astrocytes acutely dissociated from the mouse brain. For this,
brain cells were isolated from mice previously stereotaxically in-
jected with adenoassociated viruses (AAVs) expressing green
fluorescence protein (GFP) under the control of either an astrocyte
or a neuronal specific promoter. Cells were then subjected to mi-
tochondrial ROS assessment by flow cytometry analysis using
MitoSox. As shown in Fig. 2F, the MitoSox fluorescence was higher
in astrocyte promoter-driven GFP+ cells [expressing the astrocyte
specific glial-fibrillary acidic protein (GFAP)] than in neuron pro-
moter-driven GFP+ cells [expressing the neuron-specific neuronal
nuclei (NeuN)]. Moreover, freshly isolated mouse brain cells,
sorted according to the astrocyte-specific plasma membrane
protein integrin β5 (29), showed a similar difference in ROS (Fig.
S4 A and B). Finally, we found that the rate of mitochondrial
ROS production was higher in astrocytes than in neurons freshly
purified from the mouse brain using magnetic-activated cell
sorting (MACS) technology (Fig. S4C). Thus, astrocytes produce
mitochondrial ROS severalfold faster than neurons.
High ROS Production by Astrocytes Correlates with Deactive Complex I.
Given that complex I is a major source of mitochondrial ROS
(27), we analyzed the specific activity of complex I in neurons
and in astrocytes. As shown in Fig. 3A, complex I activity was
very similar in both cell types, as were the activities of other
respiratory chain complexes (Fig. S5A). The complex I inhibitor,
rotenone, stimulated mitochondrial ROS production to a great
extent in neurons, but only slightly in astrocytes; however, anti-
mycin stimulated mitochondrial ROS production in both cell
types (Fig. 2D and Fig. S2H). The mild effect of rotenone
on mitochondrial ROS production in astrocytes was intriguing.
Because rotenone stimulates forward (FET) and inhibits the
reverse (RET) electron transfer to O2 at complex I (26, 29), we
determined the contribution of RET to ROS production, and we
found that RET-mediated ROS is negligible in astrocytes (Fig.
S5 B and C). Because the ubiquinone binding site is inaccessible
in deactive complex I (30, 31), rendering it insensitive to rote-
none, we hypothesized that there were different proportions of
deactive and active complex I in neurons and astrocytes. As
shown in Fig. 3B (Fig. S5D), the proportion of deactive complex
Fig. 2. Higher mitochondrial ROS production in astrocytes than in neurons
occurs ex vivo. (A) Rates of H2O2 production assessed using the AmplexRed
assay, in intact C56BL/6 mouse neurons and astrocytes in primary culture.
(B) Mitochondrial ROS was quantified using the MitoSox assay in the intact
cells (C57BL/6) by flow cytometry. (C) Mitochondrial ROS levels assessed us-
ing MitoB probe. Ratio between MitoP (oxidized form) versus MitoB is
normalized per million of cells. (D) Mitochondrial membrane potential (Δψm)
(Left) and MitoSox fluorescence (Right) were determined in basal conditions
and after the inhibition of complex I (rotenone) or complex III (antimycin).
Rotenone or antimycin was used at 10 μM, each, for 15 min. Furthermore,
MitoSox fluorescence was evaluated after cell preincubation with the un-
coupler CCCP (10 μM, 15 min). (E) Mitochondrial H2O2 production after Δψm
abolishment with the uncoupler CCCP (10 μM). (F) Mitochondrial ROS
abundance (MitoSox) assessed by flow cytometry (FC) in freshly isolated
neurons and astrocytes from adult brain mouse expressing GFP governed
either by an astrocyte (gfa-ABC1D) or a neuronal (PGK) promoter. Cell
specificity of promoter-driven GFP expression was validated by immunoflu-
orescence (I.F.) microscopy using astrocyte (GFAP) or neuronal (NeuN)
markers. (Magnification: 40×.) Data are the mean values ± SEM from n = 3–4
independent culture preparations or n = 8 animals (Student’s t test; ANOVA
post hoc Bonferroni). *P < 0.05.
Fig. 3. Astrocytes present a high proportion of deactive complex I, with
a reduced abundance of NDUFS1 subunit. (A) Mitochondrial complex I
(rotenone-sensitive NADH-ubiquinone oxidoreductase) activity, as assessed
spectrophotometrically in cell homogenates, in astrocytes and neurons.
(B) Deactive complex I activity, as assessed by the difference in rotenone-
sensitive NADH-ubiquinone oxidoreductase activity obtained with or without
N-ethylmaleimide (NEM) (10 mM) in astrocytes and neurons. (C) Complex I
subunits, excised from complex I-containing bands from a blue native gels,
were rated according to their signal intensities. The arrow indicates the most
easily observed complex I subunit (NDUFS1) present both in free and in bound
(supercomplexes) complex I fractions in neurons and astrocytes. (D) NDUFS1
protein abundance in neurons and astrocytes, as assessed by BNGE either
followed by direct electroblotting [also with complex III-UQCRC2 plus com-
plex IV–MT-CO1 (mitochondrially encoded cytochrome C oxidase I) subunits]
or by second-dimension SDS/PAGE immunoblotting followed by densito-
metric band intensity quantification. Coomassie-stained proteins from the
BNGE were used as loading control. CIII, complex III subunit UQCRC2; CIV,
complex IV subunit MT-CO1. Data are the mean values ± SEM from n = 3–4
independent culture preparations (Student’s t test). *P < 0.05.








I is one-third (∼33%) of total complex I in astrocytes, but only
∼5% in neurons. Given that deactive complex I preferentially
transfers electrons to O2 instead of to ubiquinone (30, 31), our
results suggest that the high proportion of deactive complex I
in astrocytes may contribute to the higher mitochondrial ROS
production of these cells.
Modulation of Complex I Assembly into Supercomplexes Alters ROS
Production and Respiration in Neurons and Astrocytes. To see
whether ROS production and respiration are affected by the
proportion of complex I incorporated into supercomplexes, we
first assessed the relative abundance of complex I subunits in
complex I-containing bands from the blue native gel. The ma-
jority of complex I subunits were asymmetrically distributed, both
in astrocytes and in neurons (Fig. 3C). This is consistent with
recent work showing different states of subcomplex I aggregates
in aging (32). Interestingly, we observed that the only complex I
subunit that was distributed equally in both cell types was
NADH:ubiquinone oxidoreductase core subunit S1 (NDUFS1)
(Fig. 3C), which harbors three out of the eight Fe–S clusters of
complex I (33). Given its essential role in electron transfer, we next
assessed the NDUFS1 protein abundance. NDUFS1 protein
abundance was higher in neurons than in astrocytes, as judged by
BNGE followed by immunoblotting directly, or after second-
dimension SDS/PAGE (Fig. 3D). We found that NDUFS1 knock-
down in neurons (Fig. 4A) diminished free and supercomplex-
assembled complex I abundance (Fig. 4 B and C). Consistent with
this, ROS production increased in free complex I and in complex
I-containing supercomplexes bands excised from the blue native gel
(Fig. 4D) and in the intact NDUFS1-silenced neurons (Fig. 4E).
These effects impaired the electron transfer efficiency through the
mitochondrial respiratory chain, as judged by the decreased
pyruvate/malate-driven O2 consumption (state 3) in isolated mi-
tochondria (Fig. 4F). Conversely, NDUFS1 overexpression in as-
trocytes (Fig. 5A) increased free complex I and promoted its
assembly into supercomplexes (Fig. 5 B and C). Consistent with
this, ROS production by free complex I and complex I-containing
supercomplexes excised from the blue native gel decreased (Fig.
5D), as did ROS production in the intact NDUFS1-overexpressing
astrocytes (Fig. 5E). This was not associated with an increase in
pyruvate/malate-driven O2 consumption (state 3) (Fig. 5F), which
is consistent with the low abundance of complex III in astrocytes
limiting electron transfer to O2 (Fig. 1B). Thus, modulation of
complex I assembly into supercomplexes affects mitochondrial
O2 consumption and ROS production.
Fig. 4. NDUFS1 knockdown in neurons disassembles complex I from
supercomplexes increasing ROS and impairing mitochondrial respiration. (A)
Neurons were transfected with a siRNA against NDUFS1 (or a control siRNA),
and 3 d after, NDUFS1 protein abundance was analyzed by Western blotting
in the whole-cell extracts, followed by densitometric band quantification.
β-Actin was used as loading control. (B) Digitonin-solubilized isolated mito-
chondria from NDUFS1–knocked-down neurons were subjected to BNGE
followed by in-gel complex I activity assay, and direct electroblotting against
complex I subunit NDUFS1, and complex III (UQCRC2) plus complex IV (MT-
CO1). Bands corresponding to supercomplexes (SC) and free complex I (CI)
were excised from the blue native gels, and subjected to second-dimension
SDS/PAGE immunoblotting against NDUFS1 and NADH:ubiquinone oxido-
reductase core subunit V1 (NDUFV1) NADH:ubiquinone oxidoreductase core
subunit V1 (NDUFV1). NDUFV1 abundance was assessed to distinguish be-
tween expression or stability of complex I. Coomassie-stained proteins from
the BNGE were used as loading control. (C) Densitometric quantification
analyses of the NDUFS1 and NDUFV1 band intensities shown in B. (D) In-gel
H2O2 production in the excised SC and CI bands from the BNGE of digitonin-
solubilized isolated mitochondria from control and NDUFS1–knocked-down
neurons. H2O2 production values were normalized by the NADH de-
hydrogenase-activity band intensity obtained in the BNGE. (E) Mitochondrial
ROS assessed using the MitoSox assay in intact cells by flow cytometry.
(F) Rate of pyruvate/malate (5 mM each; 1 mM ADP)-driven mitochondrial
oxygen consumption in isolated mitochondria from neurons. CIII, complex
III subunit UQCRC2; CIV, complex IV subunit MT-CO1. Data are the mean
values ± SEM from n = 3–4 independent culture preparations (Student’s
t test). *P < 0.05.
Fig. 5. Overexpression of NDUFS1 in astrocytes assembles complex I in
supercomplexes and decreases ROS production. (A) Astrocytes were trans-
fected with the full-length NDUFS1 cDNA (or control plasmid), and 1 d after,
NDUFS1 protein abundance was analyzed by Western blotting in the whole-
cell extracts, followed by densitometric band quantification. β-Actin was
used as loading control. (B) Digitonin-solubilized isolated mitochondria from
NDUFS1-overexpressing astrocytes were subjected to BNGE followed by in-
gel complex I activity assay, and direct electroblotting against complex I
subunit NDUFS1, and complex III (UQCRC2) plus complex IV (MT-CO1). Bands
corresponding to supercomplexes (SC) and free complex I (CI) were excised
from the blue native gel, and subjected to second-dimension SDS/PAGE
immunoblotting against NDUFS1 and NDUFV1. Coomassie-stained proteins
from the BNGE were used as loading control. (C) Densitometric quantifica-
tion analyses of the NDUFS1 and NDUFV1 band intensities shown in B.
(D) In-gel H2O2 production in the excised SC and CI bands from the BNGE of
digitonin-solubilized isolated mitochondria from control and NDUFS1-over-
expressing astrocytes. H2O2 production values were normalized by the
NADH dehydrogenase-activity band intensity obtained in the BNGE.
(E) Mitochondrial ROS as assessed using the MitoSox assay in intact cells by
flow cytometry. (F) Rate of pyruvate/malate (5 mM each; 1 mM ADP)-driven
mitochondrial oxygen consumption in isolated mitochondria from astro-
cytes. CIII, complex III subunit UQCRC2; CIV, complex IV subunit MT-CO1.
Data are the mean values ± SEM from n = 3–4 independent culture prepa-
rations (Student’s t test). *P < 0.05.
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Discussion
Here, we report that neurons and astrocytes organize their mi-
tochondrial respiratory chains differently, with altered proportions
of complex I free or present in supercomplexes. In astrocytes, less
complex I is assembled into supercomplexes, leaving more free
complex I. In contrast, in neurons, more complex I is assembled
into supercomplexes. These differences correlate with changes
in ROS production and respiration, with the more free complex
I segregating with elevated ROS production. Furthermore,
these rates of mitochondrial ROS formation are altered by
reorganizing the mitochondrial respiratory chain in response to
up-modulation and down-modulation of NDUFS1 levels. In-
terestingly, the rate of ROS formation inversely correlated with
electron transfer efficiency in neurons, with NDUFS1 knock-
down impairing mitochondrial O2 consumption but increasing
ROS. In contrast, NDUFS1 overexpression in astrocytes de-
creased ROS, although it did not increase mitochondrial O2
consumption. This effect on free complex I abundance can be
explained by the reduced abundance of complex III in astrocytes
that limits the amount of complex I that can be sequestered
into supercomplexes.
The lack of effect of ADP at stimulating pyruvate/malate O2
consumption in astrocyte mitochondria is in good agreement with
the high deactive complex I proportion, and the low complex III
abundance, found in these cells. Thus, NADH-derived electrons
are inefficiently transferred to ubiquinone by deactive complex I
(30, 31), and subsequently to complex IV due to the low pro-
portion of complex III in astrocytes. Moreover, given the low
complex III abundance in astrocytes, it would be reasonable to
speculate that ubiquinone pool would be favored toward its re-
duced status, a factor known to cause complex I deactivation (34).
Whether a positive loop of complex I deactivation, which is
promoted by ROS (34), takes place in astrocytes is a tempting
possibility that remains to be explored.
Our results may help explain the different redox and bio-
energetic features of neurons and astrocytes. Thus, the greater
proportion of complex I assembled into supercomplexes in neu-
rons may contribute to the higher respiration rate of neurons
compared with astrocytes. This is consistent with the dependence
of neurons on oxidative phosphorylation for neurotransmis-
sion and survival (17–19). In contrast, the smaller proportion of
complex I that is assembled into supercomplexes in astrocytes
may contribute to their lower respiration rate and is consistent
with their more glycolytic metabolism (17–22). A further in-
triguing aspect is that the large difference in mitochondrial ROS
production between neurons and astrocytes correlates with the
amount of free complex I. This may explain why astrocytes pro-
duce more ROS than neurons, and hence are equipped with
a robust redox antioxidant system (35, 36). Indeed, astrocytes
express functionally active Nrf2 (11), a transcription factor that
is activated by ROS (37) and governs expression of a range of
antioxidant genes that protect both astrocytes and their neigh-
boring neurons (38).
In conclusion, the extent of assembly of complex I into
supercomplexes is different between neurons and astrocytes, and
contributes to some of the differences in mitochondrial metabo-
lism and ROS generation between these cells. However, the
functional and mechanistic role of supercomplexes is currently
unclear and disputed (39). In future work, it will be important
to determine whether the differences in respiration and ROS
between neurons and astrocytes are due to the properties of the
supercomplexes themselves (40), or whether the balance be-
tween the relative levels of complexes I and III is more critical.
Furthermore, it will be very interesting to explore whether
changes in complex I incorporation into supercomplexes and/or
its balance with complex III contribute to excessive ROS associ-
ated in pathological situations, such as in the dopaminergic
neuronal death in Parkinson’s disease (41–43). If so, interventions
aimed at maintaining complex I stability would be a promising
therapeutic approach against this, and other neurodegenerative
diseases.
Materials and Methods
Ethical Use of Animals.Wistar rats and C57BL/6 mice were bred at the Animal
Experimentation Unit of the University of Salamanca. All protocols were
approved by the Bioethics Committee of the University of Salamanca in
accordance with the Spanish legislation (law 6/2013).
Primary Cell Cultures. Primary cultures of Wistar rat or C57BL/6 mouse cortical
neurons and astrocytes were prepared from embryonic day 15.5–16.5
(neurons) or postnatal 0–24 h (astrocytes), as described previously (44) (SI
Materials and Methods).
Mitochondria Isolation and Solubilization. Mitochondria were isolated
according to a previously published protocol (24) and solubilized with
digitonin at 4 g/g (5 min in ice) (SI Materials and Methods).
Mitochondrial Respiration. To measure the state 3 oxygen consumption rates,
we used a Clark-type electrode (Rank Brothers). Neuronal and astrocytic cells
were recollected by trypsinization and mitochondria were immediately
obtained. Freshly isolated mitochondria (100 μg) were suspended in the
respiration medium (125 mM KCl, 2 mM KH2PO4, 1 mM MgCl2, 0.5 mg/mL
BSA, 10 mM Hepes, pH 7.4). Oxygen consumption was determined after the
addition of 5 mM pyruvate plus 5 mM malate, or 5 mM succinate (state 2),
followed by the addition of 1 mM ADP (state 3).
ROS Determination. Mitochondrial ROS was detected using the fluorescent
probe MitoSox (Life Technologies) and MitoB probe (SI Materials and
Methods). For H2O2 assessments, AmplexRed (Life Technologies) was used
(SI Materials and Methods). H2O2 measured directly form blue native gel
slices were performed in the presence of 20 μM NADH and 40 U/mL SOD
(SI Materials and Methods).
Mitochondrial Membrane Potential. The mitochondrial membrane potential
(Δψm) was assessed using the probe DiIC1 (5) (Life Technologies) (50 nM) by
flow cytometry (SI Materials and Methods).
Activity of Mitochondrial Complexes. Cells were collected and suspended in
phosphate buffer (PB: 0.1 M KH2PO4 pH 7.0). After three cycles of freeze/
thawing, to ensure cellular disruption, complex I, complex II, complex II–III,
complex IV, and citrate synthase activities were determined spectrophoto-
metrically as indicated in SI Materials and Methods.
BNGE. For the assessment of complex I organization, digitonin-solubilized
mitochondria (10–50 μg) were loaded in NativePAGE Novex 3–12% (vol/vol)
gels (Life Technologies). After electrophoresis, in-gel NADH dehydrogenase
activity was evaluated (45). After identification of individual complex I and
complex I-containing supercomplexes bands according to the NADH de-
hydrogenase activity, either a direct electrotransfer or a second-dimension
SDS/PAGE were performed to identify some subunits of the mitochondrial
complexes. Thus, individual complex I or complex I-containing supercomplexes
bands were excised from the gel and denatured in 1% SDS (containing 1%
β-mercaptoethanol) during 1 h. The proteins contained in the gel slices were
separated electrophoretically, followed by Western blotting against NDUFS1-
or NDUFV1-specific antibodies. Coomassie staining of BNGE gels was per-
formed, as an indicator of loaded protein, during 15 min followed by different
steps of destaining with 10% (vol/vol) acetic acid plus 20% (vol/vol) methanol.
Direct transfer of BNGE was performed after soaking the gels for 20 min (4 °C)
in carbonate buffer (10 mM NaHCO3, 3 mM Na2CO3·10H2O, pH 9.5–10). Pro-
teins transfer to nitrocellulose membranes was carried out at 300 mA, 60 V, 1 h
at 4 °C in carbonate buffer.
Electroelution of Proteins. Following BNGE and in-gel NADH dehydrogenase
activity, individual and complex I-containing supercomplexes bands were
excised, and the proteins electroeluted. To electroelute proteins, gel slices
were placed in an electrodialysis membrane (Dialysis Tubing-Visking;Medicall
International), and an electric field was applied during 4 h at 100 V. The
samples containing the electroeluted proteins were collected, and the
complex I-specific activity was determined.








Mass Spectrometry. Mass spectrometry analysis was carried out in the
blue native gel slices excised from the individual complex I, complex
I-containing supercomplexes, and in the interbands, at the Medical Re-
search Council Mitochondrial Biology Unit (Cambridge, UK) as described in SI
Materials and Methods.
Protein Determinations. Protein samples were quantified by the BCA protein assay
kit (Thermo) following the manufacturer’s instructions, using BSA as a standard.
Statistical Analysis. All measurements were carried out at least in three dif-
ferent culture preparations or animals, and the results were expressed as the
mean values ± SEM. For the comparisons between two groups of values, the
statistical analysis of the results was performed by Student’s t test. For
multiple-values comparisons, we used one-way ANOVA followed by the
Bonferroni test. The statistical analysis was performed using the SPSS soft-
ware. In all cases, P < 0.05 was considered significant.
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